Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Convertible Debt (2024 - 2026)

Adagio Medical Holdings has reported Convertible Debt over the past 3 years, most recently at $22.9 million for Q1 2026.

  • Quarterly Convertible Debt rose 29.57% to $22.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Mar 2026, up 29.57% year-over-year, with the annual reading at $21.0 million for FY2025, 30.88% up from the prior year.
  • Convertible Debt was $22.9 million for Q1 2026 at Adagio Medical Holdings, up from $21.0 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $22.9 million in Q1 2026 and troughed at $13.8 million in Q3 2024.
  • The 3-year median for Convertible Debt is $17.7 million (2025), against an average of $18.5 million.
  • Year-over-year, Convertible Debt surged 54.12% in 2025 and then grew 29.57% in 2026.
  • A 3-year view of Convertible Debt shows it stood at $16.1 million in 2024, then skyrocketed by 30.88% to $21.0 million in 2025, then grew by 8.71% to $22.9 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Convertible Debt are $22.9 million (Q1 2026), $21.0 million (Q4 2025), and $21.2 million (Q3 2025).